Investment Analysts’ Weekly Ratings Changes for Omada Health (OMDA)

A number of research firms have changed their ratings and price targets for Omada Health (NASDAQ: OMDA):

  • 11/16/2026 – Omada Health had its price target lowered by JPMorgan Chase & Co. from $30.00 to $25.00. They now have an “overweight” rating on the stock.
  • 11/9/2026 – Omada Health was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
  • 11/6/2026 – Omada Health had its price target lowered by Barclays from $24.00 to $22.00. They now have an “overweight” rating on the stock.
  • 11/6/2026 – Omada Health had its price target lowered by Wells Fargo & Company from $22.00 to $19.00. They now have an “equal weight” rating on the stock.
  • 11/4/2026 – Omada Health was downgraded by Zacks Research from “strong-buy” to “hold”.
  • 10/28/2026 – Omada Health had its price target lowered by Barclays from $27.00 to $24.00. They now have an “overweight” rating on the stock.
  • 10/11/2026 – Omada Health was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/8/2026 – Omada Health was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
  • 10/6/2026 – Omada Health was upgraded by Zacks Research from “hold” to “strong-buy”.
  • 10/3/2026 – Omada Health was downgraded by Wall Street Zen from “buy” to “hold”.

Omada Health Trading Down 3.5%

Omada Health stock traded down $0.44 during mid-day trading on Friday, hitting $12.06. The company had a trading volume of 686,747 shares, compared to its average volume of 1,276,406. The company has a market capitalization of $748.20 million, a price-to-earnings ratio of 57.43 and a beta of 2.13. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $25.45. The company’s fifty day moving average is $18.62 and its 200-day moving average is $17.68.

Omada Health (NASDAQ:OMDA – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.08. The firm had revenue of $91.31 million during the quarter. Omada Health had a net margin of 4.21% and a return on equity of 5.71%. As a group, sell-side analysts expect that Omada Health, Inc. will post 0.13 EPS for the current fiscal year.

Insider Activity

In related news, CEO Sean Duffy sold 12,944 shares of Omada Health stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $19.22, for a total value of $248,783.68. Following the completion of the transaction, the chief executive officer owned 382,594 shares in the company, valued at $7,353,456.68. The trade was a 3.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Wei-Li Shao sold 4,036 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total value of $88,186.60. Following the transaction, the president owned 295,313 shares in the company, valued at $6,452,589.05. This represents a 1.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 79,322 shares of company stock worth $1,720,914 in the last ninety days. Company insiders own 6.38% of the company’s stock.

Omada Health is a U.S. digital health company that provides virtual care programs for people managing chronic conditions. Its services address areas including diabetes, prediabetes, hypertension, musculoskeletal conditions and weight management. The company combines digital tools, personalized health coaching and, where appropriate, clinical support to help members build health habits and manage their care. Programs may include mobile-app-based guidance and connected devices, such as scales or blood pressure monitors.

Read More

Receive News & Ratings for Omada Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.